MYC and gastric cancer: In our networks, the inhibition of RHOA signaling by JK-206 treatment may induce the suppression of Myc targets through downregulation of BIRC5, H2AFZ, HIST1H2BK, KIF15, UBE2S, and FBXO5 in GC cells.